The effect of medical treatment on patients with fistulizing Crohn's disease: A retrospective study

Internal Medicine

Volumn 47, Issue 4, 2008, Pages 193-199

  Uza, Norimitsu ^a   Nakase, Hiroshi ^a   Ueno, Satoru ^a   Inoue, Satoko ^a   Mikami, Sakae ^a   Tamaki, Hiroyuki ^a   Matsuura, Minoru ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Crohn's disease; Fistulizing Crohn's disease; Medical therapy

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; METRONIDAZOLE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON FISTULA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FISTULIZING CROHN DISEASE; HEMICOLECTOMY; HUMAN; INTESTINE RESECTION; MALE; PARESTHESIA; REMISSION; RETROSPECTIVE STUDY; SIGMOIDECTOMY;

ADOLESCENT; ADULT; CROHN DISEASE; CUTANEOUS FISTULA; FEMALE; HUMANS; INTESTINAL FISTULA; MALE; RETROSPECTIVE STUDIES;

EID: 40749122061     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0537     Document Type: Article

References (31)

1. Williams DR, Coller JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn's disease. Dis Colon Rectum 24: 22-24, 1981.
2. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122: 875-880, 2002.
3. Lapidus A, Bernell O, Hellers G, Lofberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 114: 1151-1160, 1998.
4. Present DH. Crohn's fistula: current concepts in management. Gastroenterology 124: 1629-1635, 2003.
5. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340: 1398-1405, 1999.
6. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350: 876-885, 2004.
7. Sandborn WJ, Present DH, Isaacs KL, et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 125: 380-388, 2003.
8. Gonzalez-Lama Y, Abreu L, Vera MI, et al. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study. Inflamm Bowel Dis 11: 8-15, 2005.
9. Levy C, Tremaine WJ. Management of internal fistulas in Crohn's disease. Inflamm Bowel Dis 8: 106-111, 2002.
10. Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol 99: 445-449, 2004.
11. Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 18: 1113-1120, 2003.
12. Rutgeerts P. Review article: treatment of perianal fistulizing Crohn's disease. Aliment Pharmacol Ther 20: 106-110, 2004.
13. Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology 119: 1132-1147, 2000.
14. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83: 383-387, 1982.
15. Kruis W. Review article: antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20: 75-78, 2004.
16. O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology 101: 39-46, 1991.
17. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 302: 981-987, 1980.
18. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123: 132-142, 1995.
19. Sandborn WJ. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol 92: 876-879, 1997.
20. Ierardi E, Principi M, Rendina M, et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. J Clin Gastroenterol 30: 200-202, 2000.
21. Ierardi E, Principi M, Francavilla R, et al. Oral tacrolimus longterm therapy in patients with Crohn's disease and steroid resistance. Aliment Pharmacol Ther 15: 371-377, 2001.
22. Gonzalez Lama Y, Abreu LE, Vera MI, de la, Revilla J, Fernandez-Puga N, Escartin P. Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience. Gastroenterology 126: 942-943, 2004.
23. Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 5: 239-245, 1999.
24. Hanauer SB. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol 2: 493, 2005.
25. Caprilli R, Angelucci E, Cocco A. Early or late guided missile in the treatment of Crohn's disease? Dig Liver Dis 37: 973-979, 2005.
26. West RL, Van der, Woude CJ, Endtz HP, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 20: 1329-1336, 2004.
27. Ochsenkuhn T, Goke B, Sackmann M. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Am J Gastroenterol 97: 2022-2025, 2002.
28. Schroder O, Blumenstein I, Schulte-Bockholt A, Stein J. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine. Aliment Pharmacol Ther 19: 295-301, 2004.
29. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348: 601-608, 2003.
30. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol 97: 2962-2972, 2002.
31. Fukuda A, Nakase H, Seno H, Nabeshima M, Sawada M, Chiba T. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus. J Gastroenterol 40: 433-435, 2005.